請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43221完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳水田(Shui-Tein Chen) | |
| dc.contributor.author | Teng-Kuei Hsu | en |
| dc.contributor.author | 許登逵 | zh_TW |
| dc.date.accessioned | 2021-06-15T01:43:28Z | - |
| dc.date.available | 2011-08-14 | |
| dc.date.copyright | 2009-08-14 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-10 | |
| dc.identifier.citation | 1. Sayegh MH, Carpenter CB. Transplantation 50 years later--progress, challenges, and promises. N Engl J Med. 2004; 351(26):2761-6.
2. Al-rabia MW. Complement and hyper acute rejection. Saudi J Kidney Dis Transpl. 2009; 20(3):362-9. 3. Everson GT, Trotter JF, Kugelmas M, Forman L. Immunosuppression in liver transplantation. Minerva Chir. 2003; 58(5):725-40. 4. Feng S. Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant. 2008; 13(5):506-12. 5. Calne RY, Sells RA, Rena JR et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472–6. 6. Kamada N, Brons G, Davies HffS. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980; 29: 429–31. 7. Kamada N, Davies HFFS, Roser BJ. Reversal of transplantation immunity by liver grafting. Nature 1981; 292: 840–2. 8. Andrzejewski W, Brolsch C. Postoperative reactions of rats after orthotopic liver transplantation: a model for the human response? A histological and biochemical study. Eur Surg Res 1982; 14: 428–39. 9. Sun J, McCaughan GW, Matsumoto Y, Sheil AG, Gallagher ND, Bishop GA. Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation. 1994; 57:1349–57. 10. Farges O, Morris PJ, Dallman MJ. Spontaneous acceptance of liver allografts in the rat. Analysis of the immune response. Transplantation. 1994; 57:171–7. 11. Nakano T, Goto S, Lai CY, Hsu LW, Wong JL, Kawamoto S, Chiang KC, Ohmori N, Goto T, Sato S, Yang CH, Wang CC, Jawan B, Cheng YF, Ono K, Chen CL. Involvement of autoimmunity against nuclear histone H1 in liver transplantation tolerance. Transpl Immunol. 2008; 19(2): 87-92. 12. Görg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics. 2004; 4(12): 3665-85. 13. Conrotto P, Souchelnytskyi S. Proteomic approaches in biological and medical sciences: principles and applications. Exp Oncol. 2008; 30(3):171-80. 14. Galun E, Axelrod JH. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta. 2002; 1592(3):345-58. 15. Gornik I, Maravić G, Dumić J, Flögel M, Lauc G. Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin Biochem. 1999; 32(8):605-8. 16. Rydén I, Påhlsson P, Lundblad A, Skogh T. Fucosylation of alpha1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis. Clin Chim Acta. 2002; 317(1-2): 221-9. 17. Narisada M, Kawamoto S, Kuwamoto K, Moriwaki K, Nakagawa T, Matsumoto H, Asahi M, Koyama N, Miyoshi E. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells. Biochem Biophys Res Commun. 2008; 377(3):792-6. 18. Kamada N, Kobayashi E, Goto S. Liver transplantation in the rat. In: Green MK, Mandel TE, eds. Experimental transplantation models in small animals. Chur, Switzerland: Harwood Academic Publishers, 1995: 341–52. 19. Sugio K, Greenbaum LM. Increase in vascular permeability of rat and guinea pig skin by T-kinin. Inflammation. 1988 Oct; 12(5):407-12. 20. Furuto-Kato S, Matsumoto A, Kitamura N, Nakanishi S. Primary structures of the mRNAs encoding the rat precursors for bradykinin and T-kinin. Structural relationship of kininogens with major acute phase protein and alpha 1-cysteine proteinase inhibitor. J Biol Chem. 1985; 260(22):12054-9. 21. Sierra F, Walter R, Vautravers P, Guigoz Y. Identification of several isoforms of T-kininogen expressed in the liver of aging rats. Arch Biochem Biophys. 1995; 322(2):333-8. 22. Sueyoshi T, Enjyoji K, Shimada T, Kato H, Iwanaga S, Bando Y, Kominami E, Katunuma N. A new function of kininogens as thiol-proteinase inhibitors: inhibition of papain and cathepsins B, H and L by bovine, rat and human plasma kininogens. FEBS Lett. 1985; 182(1):193-5. 23. Walter R, Murasko DM, Sierra F. T-kininogen is a biomarker of senescence in rats. Mech Ageing Dev. 1998;106:129–144. 24. Acuña-Castillo C, Aravena M, Leiva-Salcedo E, Pérez V, Gómez C, Sabaj V, Nishimura S, Pérez C, Colombo A, Walter R, Sierra F. T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation. Mech Ageing Dev. 2005; 126(12):1284-91. 25. Hanley JM, Haugen TH, Heath EC. Biosynthesis and processing of rat haptoglobin. J Biol Chem. 1983 Jun 25;258(12):7858-69. 26. Lord R, Kamada N, Kobayashi E, Goto S, Sunagawa M. Isolation of a 40 kDa immunohibitory protein induced by rat liver transplantation. Transplant Immunol 1995; 3:174–9. 27. Pan TL, Wang PW, Huang CC, Goto S, Chen CL. Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation. Immunology. 2004; 113(1):57-64. 28. Weiss G. Modification of iron regulation by the inflammatory response. Best Pract Res Clin Haematol. 2005; 18(2):183-201. 29. Naka T, Nishimoto N & Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Research 2002; 4 (supplement 3): S233–S242. 30. Yoshizaki K, Nakagawa T, Kaieda T, Muraguchi A, Yamamura Y, Kishimoto T. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol 1982, 128: 1296-1301. 31. Hirano T. Interleukin 6 and its receptor: ten years later. International reviews of immunology 1998; 16(3-4):249-84 32. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. The Biochemical journal 1998; 334: 297-314 33. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19(21): 2548-56 34. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996; 274(5291):1379-83. 35. Chen RH, Chang MC, Su YH, Tsai YT, Kuo ML. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem. 1999; 274(33):23013-9. 36. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene. 2002; 21(1):32-43. 37. Gao B. Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Alcohol. 2004; 34(1):59-65. 38. Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H, Okuyama T, Takeda K, Akira S, Ogino T, Irani K, Ozaki M. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest. 2003; 112(7):989-98. 39. Deng MC, Plenz G, Labarrere C, Marboe C, Baba HA, Erre M, Itescu S. The role of IL6 cytokines in acute cardiac allograft rejection. Transpl Immunol. 2002; 9(2-4):115-20. 40. Perez-Villa F, Benito B, Llancaqueo M, Cuppoletti A, Roig E. Elevated levels of serum interleukin-6 are associated with low grade cellular rejection in patients with heart transplantation. Transplant Proc. 2006; 38(9):3012-5. 41. Tomura M, Nakatani I, Murachi M, Tai XG, Toyo-oka K, Fujiwara H. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production. Transplantation. 1997; 64(5):757-63. 42. Liang Y, Christopher K, Finn PW, Colson YL, Perkins DL. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Transplantation. 2007; 84(6):771-7. 43. Conley L, Geurs TL, Levin LA. Transcriptional regulation of ceruloplasmin by an IL-6 response element pathway. Brain Res Mol Brain Res. 2005; 139(2):235-41. 44. Pan TL, Chen CL, Lin CL, Lai CY, Tseng HP, Chiang KC, Lin YC, Shu LW, Chen YS, Eng HL, Jawan B, Yokoyama H, Kitano S and Goto S. Ceruloplasmin, a novel candidate as a diagnostic marker for liver function after liver transplantation. Transplant Proc. 2000; 32(7):2198. 45. Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-John S. Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes. FEBS Lett. 1992; 314(3):280-4. 46. Kalsheker NA. Alpha 1-antichymotrypsin. Int J Biochem Cell Biol. 1996; 28(9):961-4. 47. Marinković S, Baumann H. Structure, hormonal regulation, and identification of the interleukin-6- and dexamethasone-responsive element of the rat haptoglobin gene. Mol Cell Biol. 1990; 10(4):1573-83. 48. Boutten A, Venembre P, Seta N, Hamelin J, Aubier M, Durand G, Dehoux MS. Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma. Am J Respir Cell Mol Biol. 1998; 18(4):511-20. 49. Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002; 102(12):4751-804. 50. Gornik O, Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Marker. 2008; 25(4-5):267-78. 51. Arnold JN, Saldova R, Hamid UM, Rudd PM. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics. 2008 8(16):3284-93. 52. Nakagawa H, Hato M, Takegawa Y, Deguchi K, Ito H, Takahata M, Iwasaki N, Minami A, Nishimura S. Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 853(1-2):133-7. 53. Guo N, Liu Y, Masuda Y, Kawagoe M, Ueno Y, Kameda T, Sugiyama T. Repeated immunization induces the increase in fucose content on antigen-specific IgG N-linked oligosaccharides. Clin Biochem. 2005; 38(2):149-53. 54. Miyoshi E, Nakano M. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics. 2008; 8(16):3257-62 55. Hoagland LF, Campa MJ, Gottlin EB, Herndon JE, Patz EF Jr. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer. 2007; 110(10):2260-8. 56. Okuyama N, Ide Y, Nakano M, Nakagawa T, Yamanaka K, Moriwaki K, Murata K, Ohigashi H, Yokoyama S, Eguchi H, Ishikawa O, Ito T, Kato M, Kasahara A, Kawano S, Gu J, Taniguchi N, Miyoshi E. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer. 2006; 118(11):2803-8. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43221 | - |
| dc.description.abstract | 在這篇論文中，我們建立了一個自發性耐受的模式，兩種不同品系的大鼠DA與PVG在進行異體肝臟移植後，可以在不外加任何免疫抑制的處理下，自發性的對外來器官產生耐受的反應。利用功能性蛋白質體學分析在異體肝臟移植中有不同表現量的血清蛋白質，發現在這些不同表現量的蛋白質中，包括血紅素結合蛋白 (haptoglobin)以及激肽原 (kininogen)皆有報告提出具有抑制淋巴球細胞的增生能力，而因此可能降低細胞調控的排斥反應。根據這些不同表現量的蛋白質，透過生物資訊分析統計上有顯著差異的網絡 (network)，發現介白質6 (Interleukin-6)可能參與這個自發性耐受的模式。介白質6是一種具有肝臟保護能力的白血球細胞生長激素，它可以促進肝臟的再生、減少肝臟的受損以及提高具有免疫抑制能力的蛋白質例如血紅素結合蛋白的表現量。有趣的是，在這個模式中，介白質6表現的時間點正好是器官移植排斥最嚴重的時期，因此我們推測介白質6可能在這個自發性耐受上扮演關鍵的角色。此外，介白質6可以提高岩澡糖基化 (fucosylation)調控基因的表現，也支持我們所觀察到在模式中，血清蛋白質的岩澡糖基化程度有上升的情形，但是岩澡糖基化在這個模式中可能的相關功能目前尚不清楚。這些觀察到的現象暗示介白質6在異體移植中扮演著保護的角色。 | zh_TW |
| dc.description.abstract | In this report, we have established a spontaneous tolerance model in which rats could develop spontaneous tolerance without any immunosuppressive treatments after orthotopic liver transplantion between DA (RT-1a) and PVG (RT-1c) rats. Functional proteomics analysis was introduced to investigate the differently expressed proteins involved in allograft liver transplantation. Among these different-expressed proteins, both haptoglobin and kininogen were reported to inhibit the proliferation of lymphocytes, suggesting a possible role of these two proteins in down-regulate cell-mediated graft rejection. Bioinformatics analysis of the statistically significant networks based on these differently expressed proteins indicated that the IL-6 signaling pathway might be involved in this model. IL-6 is a hepatoprotective cytokine that promotes liver regeneration, reduces liver injury and up-regulates the immune- suppressive proteins such as haptoglobin. Interestingly in this model, the highest expression of IL-6 occurred at the most severe stage of allograft rejection; thus we hypothesize that IL-6 might be the key contributor to spontaneous tolerance. Furthermore, it has been previously shown that IL-6 can also up-regulate the fucosylation regulatory genes, which supports our observation of an increase of fucosylation levels in serum protein; yet the related functions of fucosylation in this model remained unclear. These observations suggest that IL-6 plays a protective role in the spontaneous tolerance DA/PVG OLT model. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T01:43:28Z (GMT). No. of bitstreams: 1 ntu-98-R96b46018-1.pdf: 7725434 bytes, checksum: ff1527b5fe6f1df662f35f4a80216c88 (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | Acknowledgements 2
Abstract (Chinese) 4 Abstract (English) 5 Abbreviations 10 Lists of Figures 12 Lists of Figures 13 1. Introduction 14 1.1. Organ transplantation 14 1.2. Transplantation rejection and immunosuppressive therapy 15 1.3. Spontaneous tolerance orthotopic liver transplantation 16 1.4. Functional proteomics analysis 17 1.5. Investigation of IL-6 related responses in DA/PVG OLT model 19 2. Materials and Methods 21 2.1. Orthotopic liver transplantation 21 2.2. Sample preparation 21 2.3. Two-dimensional gel electrophoresis (2DE) 21 2.4. Two-dimensional difference gel electrophoresis (2D-DIGE) 22 2.5. In-gel digestion for protein identification 23 2.6. Mass spectrometry analysis 24 2.7. Bioinformatics analysis 25 2.8. Enzyme-linked immunosorbent assay (ELISA) of IL-6 26 2.9. Western blot assay 26 2.10. Lectin blot assay 27 3. Results 29 3.1. Analysis of protein expression in DA/PVG OLT model 29 3.2. Identification of different-expressed serum protein 29 3.3. Functional networks analysis of DA/PVG OLT model 30 3.4. ELISA Quantification of IL-6 30 3.5. The expression time course of haptoglobin,α1-antitrypsin, and ceruloplasmin 31 3.6. Lectin blot analysis the fucosylation of serum protein 31 4. Discussion 33 4.1. Functional proteomics analysis in DA/PVG OLT model 33 4.2. Potential immunosuppressive proteins 33 4.3. Bioinformatics network analysis in DA/PVG OLT model 34 4.4. Il-6 signaling pathway 35 4.5. Role of IL-6 in organ transplantation 36 4.6. IL-6 regulated proteins 37 4.7. The expression time course of IL-6 and IL-6 regulated proteins 38 4.8. Glycan modification in DA/PVG OLT model 39 4.9. Conculsion 40 5. Reference 42 6. Figures 51 7. Tables 69 | |
| dc.language.iso | en | |
| dc.subject | 血紅素結合蛋白 | zh_TW |
| dc.subject | 肝臟移植 | zh_TW |
| dc.subject | 免疫抑制 | zh_TW |
| dc.subject | 排斥 | zh_TW |
| dc.subject | 耐受 | zh_TW |
| dc.subject | 蛋白質體 | zh_TW |
| dc.subject | 介白質6 | zh_TW |
| dc.subject | 激肽 | zh_TW |
| dc.subject | 原 | zh_TW |
| dc.subject | kininogen | en |
| dc.subject | haptoglobin | en |
| dc.subject | orthotopic liver transplantion | en |
| dc.subject | immunosuppressive | en |
| dc.subject | allograft rejection | en |
| dc.subject | tolerance | en |
| dc.subject | proteomics | en |
| dc.subject | IL-6 | en |
| dc.title | 從DA-PVG大鼠排斥與耐受模式探討肝臟移植的免疫機制 | zh_TW |
| dc.title | Exploring the Mechanism of Immunological Responses in Liver Transplantation–From Rejection to Tolerance in DA-PVG Model | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 潘台龍(Tai-Long Pan),阮雪芬(Hsueh-Fen Juan) | |
| dc.subject.keyword | 肝臟移植,免疫抑制,排斥,耐受,蛋白質體,介白質6,激肽,原,血紅素結合蛋白, | zh_TW |
| dc.subject.keyword | orthotopic liver transplantion,immunosuppressive,allograft rejection,tolerance,proteomics,IL-6,kininogen,haptoglobin, | en |
| dc.relation.page | 69 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-07-13 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科學研究所 | zh_TW |
| 顯示於系所單位： | 生化科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 7.54 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。